Eighteen monoclonal antibodies (MAbs) directed against the purified human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) protein were produced. The antibodies were characterized by competitive ELISAs and Western blot experiments, and with nested, nine amino acid long peptides representing the whole 560 amino acid RT protein. By ELISA, the MAbs react with a minimum of seven epitopes of the protein. Four of the epitopes were located on the N-terminal 51K subunit and the remaining three epitopes were located at the C-terminal end of the protein. Using synthetic peptides, two epitopes at the N-terminal part were located at amino acids 294 to 302 and 350 to 354, respectively, from the N-terminal start of the protein. One epitope was located at amino acids 442 to 450, just after the cleavage site between the N-terminal and C-terminal subunit at position 440. Antibodies located at amino acids 294 to 302 could inhibit the RT enzymic activity of the protein. Two other MAbs, directed at the N-terminal and C-terminal parts of the protein, could also inhibit RT activity.
Dt Marzo VeroneseF.,
CopelandT. D.,
De VicoA. L.,
RahmanR.,
OroszlanS.,
GalloR. C.,
SarngadharanM. G.1986; Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231:1289–1291
FarmerieW. G.,
LoebD. D.,
CasavantN. C.,
HutchinsonC. A.,
EdgellM. H.,
SwanstromR.1987; Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli
. Science 236:305–308
GeysenH. M.,
MeloenR. H.,
BartelingS. J.1984; Use of peptide synthesis to probe viral antigens for epitopes to resolution of a single amino acid. Proceedings of the National Academy of Sciences, U,. S,. A 81:3998–4002
GronowitzJ. S.,
NeumüllerM.,
LennerstrandJ.,
BhikhabhaiR.,
UngeT.,
WeltmanH.,
KallanderC. F. R.1991; Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses with special reference to HIV. Biotechnology and Applied Biochemistry (in press)
HansenJ.,
SchulzeT.,
MellertW.,
MoellingK.1988; Identification and characterization of HIV-specific RNase H by monoclonal antibodies. EMBO Journal 7:239–243
HiziA.,
McGillC.,
HughesS. H.1987; Expression of soluble enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proceedings oj the National Academy of Sciences, U.S.A 85:1218–1222
HiziA.,
BarberA.,
HughesS. H.1989; Effects of small insertions on the RNA-dependent DNA polymerase activity of HIV-1 reverse transcriptase. Virology 170:326–329
HiziA.,
HughesS. H.,
ShaharabanyM.1990; Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase. Virology 175:575–580
JohnsonM. S.,
McClureM. A.,
FengD. F.,
GrayJ.,
DoolittleR. F.1986; Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proceedings of the National Academy of Sciences, U,. S,. A 83:7648–7652
KotewiczM. L.,
SampsonC. M.,
D’AlessioJ. M.,
GerardG. F.1988; Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity. Nucleic Acids Research 16:265–277
LarderB.,
PurifoyD.,
PowellK.,
DarbyG.1987a; AIDS virus reverse transcriptase defined by high level expression in Escherichia coli
. EMBO Journal 6:3133–3137
LarderB. A.,
KempS. D.,
PurifoyD. J. M.1989; Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proceedings of the National Academy of Sciences, U,. S,. A 86:4803–4807
Le GriceS. F. J.,
ZehnleR.,
MousJ.1988; A single 66-kilodalton polypeptide processed from human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity. Journal of Virology 62:2525–2529
LightfooteM. M.,
ColiganJ. E.,
FolksT. M.,
FauciA. S.,
MartinM. A.,
VenkatesanS.1986; Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. Journal of Virology 60:771–775
MizrahiV.,
UsdinM. T.,
HaringtonA.,
DuddingL. R.1990; Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase. Nucleic Acids Research 18:5359–5363
MousJ.,
HeimerE. P.,
Le GriceS. F. J.1988; Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli
. Journal of Virology 62:1433–1436
NeumüllerM.,
KarlströmA. R.,
KällanderC. F. R.,
GronowitzJ. S.1990; Improved assays for DNA-polymerizing enzymes by the use of enzymatically synthesized 5-[125I]iodo-2–-deoxyuridine triphosphate, illustrated by direct quantitation of anti-HIV reverse transcriptase antibody and by serum DNA polymerase analysis. Biotechnology and Applied Biochemistry 12:34–56
NeumüllerM.,
KarlssonA.,
LennerstrandJ.,
KällanderC. F. R.,
HolmbergV.,
Langström-PerssonU.,
ThorstenssonR.,
SandströmE.,
GronowitzJ. S.1991; HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables. Journal of Medical Virology 34:55–63
OhlinM.,
SundqvistV. A.,
GilliamG.,
RudenU.,
GombertF.,
WahrenB,
BorrebaeckC. A. K.
1991; Characterization of human monoclonal antibodies directed against the pp65 kD matrix antigen of human cytomegalovirus. Journal of Clinical and Experimental Immunology (in press)
ÖrvellC.,
GrandienM.1982; The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. Journal of Immunology 129:2779–2787
ÖrvellC.,
SheshberadaranH.,
NorrbyE.1985; Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus. Journal of General Virology 66:443–456
ÖrvellC.,
NorrbyE.,
MufsonM. A.1987; Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. Journal of General Virology 68:3125–3135
PrasadV. R.,
GoffS. P.1989; Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain. Proceedings of the National Academy of Sciences, U,. S,. A. 86:3104–3108
TaneseN.,
GoffS. P.1988; Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proceedings of the National Academy of Sciences, U,. S,. A. 85:1777–1781
TisdaleM.,
ErtlP.,
LarderB. A.,
PurifoyD. J. M.,
DarbyG.,
PowellK. L.1988; Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function. Journal of Virology 62:3662–3667
UngeT.,
AholaH.,
BhikhabhaiR.,
BäckbroK.,
LövgrenS.,
FenyöE. M.,
HonigmanA.,
PanetA.,
GronowitzJ. S.,
StrandbergB.1990; Expression, purification and crystallization of the HIV-1 reverse transcriptase. AIDS Research and Human Retroviruses 6:1297–1303
WilsonB. M.,
NakaneP. K.1978; Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In Immunofluorescence and Related Staining Techniques p 215 Edited by
KnappW.,
HolubatK.,
WickG.
Amsterdam: Elsevier/North-Holland: